These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 8183178

  • 1. Preventive treatment of cortical bone loss with salmon nasal calcitonin in early postmenopausal women.
    Mango D, Ricci S, Manna P, Natili G, Dell'Acqua S.
    Minerva Endocrinol; 1993 Sep; 18(3):115-21. PubMed ID: 8183178
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
    Reginster JY, Deroisy R, Lecart MP, Sarlet N, Zegels B, Jupsin I, de Longueville M, Franchimont P.
    Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
    [Abstract] [Full Text] [Related]

  • 3. Early effect of nasal salmon calcitonin on the bone marker Crosslaps.
    Ofluoglu D, Karadag-Saygi E, Canbulat C, Gunduz OH, Kul-Panza E, Akyuz G.
    Rheumatol Int; 2006 Feb; 26(4):288-91. PubMed ID: 15875189
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
    Tankó LB, Bagger YZ, Alexandersen P, Devogelaer JP, Reginster JY, Chick R, Olson M, Benmammar H, Mindeholm L, Azria M, Christiansen C.
    J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
    [Abstract] [Full Text] [Related]

  • 5. Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment.
    Overgaard K, Hansen MA, Nielsen VA, Riis BJ, Christiansen C.
    Am J Med; 1990 Jul; 89(1):1-6. PubMed ID: 2152594
    [Abstract] [Full Text] [Related]

  • 6. Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis.
    Thamsborg G, Jensen JE, Kollerup G, Hauge EM, Melsen F, Sorensen OH.
    Bone; 1996 Feb; 18(2):207-12. PubMed ID: 8833216
    [Abstract] [Full Text] [Related]

  • 7. Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: a dose-response study.
    Overgaard K.
    Calcif Tissue Int; 1994 Aug; 55(2):82-6. PubMed ID: 7953984
    [Abstract] [Full Text] [Related]

  • 8. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
    Agnusdei D, Gonnelli S, Camporeale A, Batignani T, Nardi P, Ianes A, Gennari C.
    Minerva Endocrinol; 1989 Aug; 14(3):169-76. PubMed ID: 2695815
    [Abstract] [Full Text] [Related]

  • 9. Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal women.
    Rizzoli R, Sigaud A, Azria M, Herrmann FR.
    Osteoporos Int; 2015 Jan; 26(1):383-93. PubMed ID: 25566730
    [Abstract] [Full Text] [Related]

  • 10. Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis.
    Adami S, Passeri M, Ortolani S, Broggini M, Carratelli L, Caruso I, Gandolini G, Gnessi L, Laurenzi M, Lombardi A.
    Bone; 1995 Oct; 17(4):383-90. PubMed ID: 8573412
    [Abstract] [Full Text] [Related]

  • 11. Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause.
    Melis GB, Cagnacci A, Bruni V, Falsetti L, Jasonni VM, Nappi C, Polatti F, Volpe A.
    Maturitas; 1996 May; 24(1-2):83-90. PubMed ID: 8794438
    [Abstract] [Full Text] [Related]

  • 12. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
    Reginster JY, Denis D, Deroisy R, Lecart MP, De Longueville M, Zegels B, Sarlet N, Noirfalisse P, Franchimont P.
    J Bone Miner Res; 1994 Jan; 9(1):69-73. PubMed ID: 8154311
    [Abstract] [Full Text] [Related]

  • 13. Acute effects of nasal salmon calcitonin on calcium and bone metabolism.
    Thamsborg G, Skousgaard SG, Daugaard H, Schifter S, Kollerup G, Sørensen OH.
    Calcif Tissue Int; 1993 Oct; 53(4):232-6. PubMed ID: 8275350
    [Abstract] [Full Text] [Related]

  • 14. The effect of intranasal salmon calcitonin on biochemical parameters of bone turnover in postmenopausal women.
    Balint-Perić LA, Prelević GM, Beslagić Z, Petrović J.
    Gynecol Endocrinol; 1994 Dec; 8(4):241-5. PubMed ID: 7709763
    [Abstract] [Full Text] [Related]

  • 15. Treatment of postmenopausal osteoporosis with salmon calcitonin nasal spray: evaluation by bone mineral content and biochemical patterns.
    Tolino A, Romano L, Ronsini S, Riccio S, Montemagno U.
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):358-60. PubMed ID: 8370634
    [Abstract] [Full Text] [Related]

  • 16. [Prevention of post-ovariectomy osteoporosis in the rat. Comparative study of synthetic salmon calcitonin and eel calcitonin aminosuberic analogue].
    Gnudi S, Zati A, Giardino R, Fini M, Pratelli L, Orlandi M, Figus E.
    Minerva Endocrinol; 1993 Sep; 18(3):123-7. PubMed ID: 8183179
    [Abstract] [Full Text] [Related]

  • 17. Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis.
    Overgaard K, Hansen MA, Dirksen KL, Christiansen C.
    Calcif Tissue Int; 1992 Sep; 51(3):184-8. PubMed ID: 1422962
    [Abstract] [Full Text] [Related]

  • 18. Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis.
    Ellerington MC, Hillard TC, Whitcroft SI, Marsh MS, Lees B, Banks LM, Whitehead MI, Stevenson JC.
    Calcif Tissue Int; 1996 Jul; 59(1):6-11. PubMed ID: 8661976
    [Abstract] [Full Text] [Related]

  • 19. Salmon calcitonin in the prevention of bone loss at perimenopause.
    Arnala I, Saastamoinen J, Alhava EM.
    Bone; 1996 Jun; 18(6):629-32. PubMed ID: 8806006
    [Abstract] [Full Text] [Related]

  • 20. [Effect of low calcitonin doses on bone remodeling in postmenopausal women with high bone turnover rate].
    Campusano C, López JM, Campino C, Cárdenas I, Rojas A.
    Rev Med Chil; 2000 Apr; 128(4):387-91. PubMed ID: 10962855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.